other material
confidence high
sentiment neutral
materiality 0.70
Aptevo raises up to $6.2M via warrant exercise inducement; issues new warrants at $9.53
Aptevo Therapeutics Inc.
- Holders exercise up to 823,544 existing warrants at $7.50/share for ~$6.2M gross proceeds.
- Company issues new warrants to buy 200% of shares exercised at $9.53, 5-year term.
- Roth Capital gets 7% advisory fee; proceeds used for working capital.
- Resale registration statement for new warrant shares due by Dec. 27, 2024.